To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.

NCT05196295 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases
Metabolic Disease

Interventions

DRUG: Hydrogen

Sponsor

HoHo Biotech